VF
HOWL icon

Virtu Financial’s Werewolf Therapeutics HOWL Stock Holding History

Virtu Financial’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+45,467
New +$27.7K ﹤0.01% 1375
2025
Q4 		– Sell
-12,230
Closed -$24K – 1892
2025
Q3 		$24K Buy
+12,230
New +$16.7K ﹤0.01% 1254
2024
Q1 		– Sell
-20,383
Closed -$79K – 1691
2023
Q4 		$79K Buy
+20,383
New +$52.1K 0.01% 1076

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Virtu Financial's HOWL Position: Q2 2026 in Review

Virtu Financial opened a new position in Werewolf Therapeutics (HOWL) in Q2 2026: 45,467 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: Virtu Financial previously reported a position in HOWL as recently as Q3 2025.

Virtu Financial first reported a position in HOWL in Q4 2023 and has held it in 3 quarters since. The position peaked at $79K in Q4 2023. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Virtu Financial held 45,467 shares of Werewolf Therapeutics worth $16K as of Q2 2026.
  • Werewolf Therapeutics was a new Virtu Financial position in Q2 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1375 holding.
  • Virtu Financial first reported a position in Werewolf Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Virtu Financial's Werewolf Therapeutics position peaked at $79K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.